The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac G sα Overexpression
Abstract
Abstract To study the physiological effect of the overexpression of myocardial G sα (protein levels increased by approximately threefold in transgenic mice), we examined the responsiveness to sympathomimetic amines by echocardiography (9 MHz) in five transgenic mice and five control mice (both 10.3±0.2 months old). Myocardial contractility in transgenic mice, as assessed by left ventricular (LV) fractional shortening (LVFS) and LV ejection fraction (LVEF), was not different from that of control mice at baseline (LVFS, 40±3% versus 36±2%; LVEF, 78±3% versus 74±3%). LVFS and LVEF values in transgenic mice during isoproterenol (ISO, 0.02 μg/kg per minute) infusion were higher than the values in control mice (LVFS, 68±4% versus 48±3%; LVEF, 96±1% versus 86±3%; P <.05). Norepinephrine (NE, 0.2 μg/kg per minute) infusion also increased LVFS and LVEF in transgenic mice more than in control mice (LVFS, 59±4% versus 47±3%; LVEF, 93±2% versus 85±3%; P <.05). Heart rates of transgenic mice were higher than those of control mice during ISO and NE infusion. In three transgenic mice with heart rates held constant, LV dP/dt rose by 33±2% with ISO (0.02 μg/kg per minute) and by only 13±2% in three wild-type control mice ( P <.01). NE (0.1 μg/kg per minute) also induced a greater effect on LV dP/dt in the three transgenic mice with heart rates held constant compared with three wild-type control mice (65±8% versus 28±4%, P <.05). Pathological and histological analyses of older transgenic mouse hearts (16.0±0.8 months old) revealed hypertrophy, degeneration, atrophy of cells, and replacement fibrosis reflected by significant increases in collagen volume in the subendocardium (5.2±1.4% versus 1.2±0.3%, P <.05) and in the cross-sectional area of myocytes (298±29 versus 187±12 μm 2 , P <.05) compared with control mouse hearts. These results suggest that G sα overexpression enhances the efficacy of the β-adrenergic receptor–G s –adenylyl cyclase signaling pathway. This in turn leads to augmented inotropic and chronotropic responses to endogenous sympathetic stimulation. This action over the life of the animal results in myocardial damage characterized by cellular degeneration, necrosis, and replacement fibrosis, with the remaining cells undergoing compensatory hypertrophy. As a model, this transgenic mouse offers new insights into the mechanisms of cardiomyopathy and heart failure and provides a new tool for their study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., & Lefkowitz, R. J. (1994) · Science · doi:10.1126/science.8160017 · Cited by 740
Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK Inhibitor
Koch, W. J., Rockman, H. A., Samama, P., Hamilton, R., Bond, R. A., Milano, C. A., & Lefkowitz, R. J. (1995) · Science · doi:10.1126/science.7761854 · Cited by 719
Adenylyl cyclases and the interaction between calcium and cAMP signalling
Cooper, D. M. F., Mons, N., & Karpen, J. W. (1995) · Nature · doi:10.1038/374421a0 · Cited by 600
Xamoterol in severe heart failure
(1990) · The Lancet · doi:10.1016/0140-6736(90)91517-e · Cited by 464
Waagstein, F., Caidahl, K., Wallentin, I., Bergh, C. H., & Hjalmarson, A. (1989) · Circulation · doi:10.1161/01.cir.80.3.551 · Cited by 446
Heilbrunn, S. M., Shah, P., Bristow, M. R., Valantine, H. A., Ginsburg, R., & Fowler, M. B. (1989) · Circulation · doi:10.1161/01.cir.79.3.483 · Cited by 427
Olsen, S. L., Gilbert, E. M., Renlund, D. G., Taylor, D. O., Yanowitz, F. D., & Bristow, M. R. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00012-s · Cited by 373
Xamoterol in severe heart failure
Ikram, H., & Crozier, I. G. (1990) · The Lancet · doi:10.1016/0140-6736(90)92078-v · Cited by 349
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis.
Benjamin, I. J., Jalil, J. E., Tan, L. B., Cho, K., Weber, K. T., & Clark, W. A. (1989) · Circulation Research · doi:10.1161/01.res.65.3.657 · Cited by 343
Metra, M., Nardi, M., Giubbini, R., & Cas, L. D. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90174-0 · Cited by 320
Hoit, B. D., Khoury, S. F., Kranias, E. G., Ball, N., & Walsh, R. A. (1995) · Circulation Research · doi:10.1161/01.res.77.3.632 · Cited by 241
Kume, H., Graziano, M. P., & Kotlikoff, M. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11051 · Cited by 168
Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure
Krell, M. J., Kline, E. M., Bates, E., Hodgson, J. M., Dilworth, L. R., Laufer, N., Vogel, R. A., & Pitt, B. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90475-8 · Cited by 153
Stoichiometry of receptor‐G s ‐adenylate cyclase interactions
Alousi, A. A., Jasper, J. R., Insel, P. A., & Motulsky, H. J. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.9.1650314 · Cited by 141
Overexpression of Gs alpha protein in the hearts of transgenic mice.
Gaudin, C., Ishikawa, Y., Wight, D. C., Mahdavi, V., Nadal‐Ginard, B., Wagner, T. E., Vatner, D. E., & Homcy, C. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117843 · Cited by 141
Self-citationLong-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
Lambertz, H., Meyer, J., & Erbel, R. M. (1984) · Circulation · doi:10.1161/01.cir.69.2.298 · Cited by 97
Hittinger, L., MIRSKY, I., Shen, Y., Patrick, T. A., Bishop, S. P., & Vatner, S. F. (1995) · Circulation · doi:10.1161/01.cir.92.4.978 · Cited by 81
Self-citationBomsel, M., & Mostov, K. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74464-0 · Cited by 69
Transgenic Manipulation of Myocardial G Protein–Coupled Receptors and Receptor Kinases
Koch, W. J., Milano, C. A., & Lefkowitz, R. J. (1996) · Circulation Research · doi:10.1161/01.res.78.4.511 · Cited by 38
C-myc protooncogene modulates cardiac hypertrophic growth in transgenic mice
Robbins, R. J., & Swain, J. L. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.2.h590 · Cited by 36
Cited by
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
Signaling Pathways for Cardiac Hypertrophy and Failure
Hunter, J. J., & Chien, K. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411706 · Cited by 869
Kubota, T., McTiernan, C. F., Frye, C. S., Slawson, S. E., Lemster, B. H., Koretsky, A. P., Demetris, A. J., & Feldman, A. M. (1997) · Circulation Research · doi:10.1161/01.res.81.4.627 · Cited by 829
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Metadata
- Authors
- Iwase, M., Bishop, S. P., Uechi, M., Vatner, D. E., Shannon, R. P., Kudej, R. K., Wight, D. C., Wagner, T. E., Ishikawa, Y., Homcy, C. J., & Vatner, S. F.
- Venue
- Circulation Research
- Published
- 1996-04
- Volume
- 78
- Issue
- 4
- Pages
- 517-524
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2124075001
- Cited by
- 267
- References
- 23
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.